1. Home
  2. WCT vs SEPN Comparison

WCT vs SEPN Comparison

Compare WCT & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WCT
  • SEPN
  • Stock Information
  • Founded
  • WCT 2012
  • SEPN 2022
  • Country
  • WCT Hong Kong
  • SEPN United States
  • Employees
  • WCT N/A
  • SEPN N/A
  • Industry
  • WCT
  • SEPN
  • Sector
  • WCT
  • SEPN
  • Exchange
  • WCT NYSE
  • SEPN NYSE
  • Market Cap
  • WCT N/A
  • SEPN 899.5M
  • IPO Year
  • WCT 2024
  • SEPN 2024
  • Fundamental
  • Price
  • WCT $7.75
  • SEPN $26.00
  • Analyst Decision
  • WCT
  • SEPN
  • Analyst Count
  • WCT 0
  • SEPN 0
  • Target Price
  • WCT N/A
  • SEPN N/A
  • AVG Volume (30 Days)
  • WCT 1.6M
  • SEPN 561.6K
  • Earning Date
  • WCT 11-19-2024
  • SEPN 11-15-2024
  • Dividend Yield
  • WCT N/A
  • SEPN N/A
  • EPS Growth
  • WCT 20.11
  • SEPN N/A
  • EPS
  • WCT 0.05
  • SEPN N/A
  • Revenue
  • WCT $2,489,995.00
  • SEPN $838,000.00
  • Revenue This Year
  • WCT N/A
  • SEPN N/A
  • Revenue Next Year
  • WCT N/A
  • SEPN N/A
  • P/E Ratio
  • WCT $159.13
  • SEPN N/A
  • Revenue Growth
  • WCT 49.00
  • SEPN N/A
  • 52 Week Low
  • WCT $3.45
  • SEPN $18.62
  • 52 Week High
  • WCT $9.34
  • SEPN $26.34
  • Technical
  • Relative Strength Index (RSI)
  • WCT N/A
  • SEPN N/A
  • Support Level
  • WCT N/A
  • SEPN N/A
  • Resistance Level
  • WCT N/A
  • SEPN N/A
  • Average True Range (ATR)
  • WCT 0.00
  • SEPN 0.00
  • MACD
  • WCT 0.00
  • SEPN 0.00
  • Stochastic Oscillator
  • WCT 0.00
  • SEPN 0.00

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

Share on Social Networks: